OnCo
targetsTarget

GRIN2A

aka glutamate ionotropic receptor NMDA type subunit 2A, Glutamate receptor ionotropic, NMDA 2A, GluN2A, NR2A, NMDAR2A

GRIN2A (Glutamate receptor ionotropic, NMDA 2A) is a gene that drives cell growth when it is altered. The public catalogues list it as a drug target, an oncogene driver and a fusion partner, and clinical evidence ties its variants to diagnosis, prognosis or drug response. Tied to Colorectal cancer, Lung cancer, Skin cancer and 5 more.